Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...

Novo says supply now meets or exceeds current and projected demand Compounders given 60- to 90-day grace period Hims & Hers shares down 22% Feb 21 (Reuters) - The U.S. Food and Drug Administration ...

BP chairman Helge Lund (pictured), has overseen a number of strategy U-turns since taking the helm in 2019. Shares have since ...

For decades, scientists believed that infections were determined solely by viruses and bacteria. But Professor Jean-Laurent ...

The NoVo Foundation reported to the IRS that it had $545,384,793 in total assets value at the end of 2023. The organization ...

Dutch tank storage company Vopak reported 2024 core earnings above its guidance range on Wednesday, driven by strong demand ...

EUROPEAN shares closed slightly higher on Tuesday, after gains in banks and healthcare companies offset declines in ...

By Nikhil Sharma (Reuters) -European shares advanced on Tuesday, as gains in defence stocks outweighed technology losses ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Follow along for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite.

European shares closed slightly higher on Tuesday, after gains in banks and healthcare companies offset declines in ...